Woo SJ - Search Results

1

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice.

Seo S, Kim KL, Yeo Y, Kim RI, Jeong H, Kim JO, Song SH, An MJ, Kim JW, Hong HK, Ham MH, Woo SJ, Sung JH, Park SG, Suh W. Seo S, et al. Among authors: woo sj. Pharmaceutics. 2021 Aug 20;13(8):1308. doi: 10.3390/pharmaceutics13081308. Pharmaceutics. 2021. PMID: 34452268 Free PMC article.

2

Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity.

Hong HK, Lee HJ, Ko JH, Park JH, Park JY, Choi CW, Yoon CH, Ahn SJ, Park KH, Woo SJ, Oh JY. Hong HK, et al. Among authors: woo sj. J Neuroinflammation. 2014 May 15;11:87. doi: 10.1186/1742-2094-11-87. J Neuroinflammation. 2014. PMID: 24886524 Free PMC article.

3

Identification of vinculin as a potential plasma marker for age-related macular degeneration.

Kim HJ, Woo SJ, Suh EJ, Ahn J, Park JH, Hong HK, Lee JE, Ahn SJ, Hwang DJ, Kim KW, Park KH, Lee C. Kim HJ, et al. Among authors: woo sj. Invest Ophthalmol Vis Sci. 2014 Oct 8;55(11):7166-76. doi: 10.1167/iovs.14-15168. Invest Ophthalmol Vis Sci. 2014. PMID: 25298412

4

The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.

Kim SR, Im JE, Jeong JH, Kim JY, Kim JT, Woo SJ, Sung JH, Park SG, Suh W. Kim SR, et al. Among authors: woo sj. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1201-6. doi: 10.1167/iovs.15-18065. Invest Ophthalmol Vis Sci. 2016. PMID: 26978025

5

Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization.

Lee J, Ryoo NK, Han H, Hong HK, Park JY, Park SJ, Kim YK, Sim C, Kim K, Woo SJ, Park KH, Kim H. Lee J, et al. Among authors: woo sj. Mol Pharm. 2016 Jun 6;13(6):1988-95. doi: 10.1021/acs.molpharmaceut.6b00148. Epub 2016 May 23. Mol Pharm. 2016. PMID: 27173745

6

Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model.

Park SJ, Choi Y, Na YM, Hong HK, Park JY, Park KH, Chung JY, Woo SJ. Park SJ, et al. Among authors: woo sj. Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2612-7. doi: 10.1167/iovs.16-19204. Invest Ophthalmol Vis Sci. 2016. PMID: 27258433

7

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs.

Ahn SJ, Hong HK, Na YM, Park SJ, Ahn J, Oh J, Chung JY, Park KH, Woo SJ. Ahn SJ, et al. Among authors: woo sj. J Vis Exp. 2016 Jul 23;(113):53878. doi: 10.3791/53878. J Vis Exp. 2016. PMID: 27500363 Free PMC article.

8

Proteomics-based identification and validation of novel plasma biomarkers phospholipid transfer protein and mannan-binding lectin serine protease-1 in age-related macular degeneration.

Kim HJ, Ahn SJ, Woo SJ, Hong HK, Suh EJ, Ahn J, Park JH, Ryoo NK, Lee JE, Kim KW, Park KH, Lee C. Kim HJ, et al. Among authors: woo sj. Sci Rep. 2016 Sep 8;6:32548. doi: 10.1038/srep32548. Sci Rep. 2016. PMID: 27605007 Free PMC article.

9

Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.

Joo K, Park SJ, Choi Y, Lee JE, Na YM, Hong HK, Park KH, Kim HM, Chung JY, Woo SJ. Joo K, et al. Among authors: woo sj. Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4261-4267. doi: 10.1167/iovs.17-21813. Invest Ophthalmol Vis Sci. 2017. PMID: 28850637

10

Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization.

Ryoo NK, Lee J, Lee H, Hong HK, Kim H, Lee JB, Woo SJ, Park KH, Kim H. Ryoo NK, et al. Among authors: woo sj. Nanoscale. 2017 Oct 19;9(40):15461-15469. doi: 10.1039/c7nr03142d. Nanoscale. 2017. PMID: 28976519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

481 results

Search Page